Organic sulfonic acids and derivatives

Organic compounds that consist of sulfonic acid with organic functional group substitutions; includes compounds that are derived from organic sulfonic acids.

Search Within Results

1,156 – 1,170 of 2,017 results

1,156

Aobchem AOBCHEM

5000903601 PHENYL 4-PROPOXYPHENYL METHANO

Pricing & Availability

1,157

eMolecules 1034558-51-4 | 1-Methyl-3-(3-sulfopropyl)-1H-imidazol-3-ium chloride | Ambeed240.700 | C7H13ClN2O3S | 95.000 | [Cl-].Cn1cc[n+](CCCS(O)(=O)=O)c1 | 1g | 660581064

1-Methyl-3-(3-sulfopropyl)-1H-imidazol-3-ium chloride | Ambeed | 1034558-51-4240.700 | C7H13ClN2O3S | 95.000 | [Cl-].Cn1cc[n+](CCCS(O)(=O)=O)c1 | 1g | 660581064

Pricing & Availability

1,158

eMolecules 40880-56-6 | N-(naphthalen-2-yl)acetohydrazide | MFCD00453481 | 250mg

Medchem Express | 7BIO | 5mg | 705860392 | HY-121035 | 916440-85-2 | 356.179 | C16H10BrN3O2

If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>

Pricing & Availability

1,159

Aobchem AOBCHEM

5000903899 1- CYCLOHEXYLOXY -4-NITROBENZE

Pricing & Availability

1,160

eMolecules 77883-43-3 | Doxazosin mesylate | Ambeed | MFCD00216023 | 547.580 | C24H29N5O8S | 99.000 | CS(O)(=O)=O.COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2ccccc2O1 | 1mg | 761204826

Doxazosin mesylate | Ambeed | 77883-43-3 | MFCD00216023 | 547.580 | C24H29N5O8S | 99.000 | CS(O)(=O)=O.COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2ccccc2O1 | 1mg | 761204826

Pricing & Availability

1,161

eMolecules 1621274-19-8 | ChemScene | XantPhos Pd G4 | 100mg | 746309886 | CS-0080720 | 961.38 | C53H46NO4P2PdS

Medchem Express | USP15-IN-1 | 5mg | 779534784 | HY-148046 | 2260826-16-0 | 377.444 | C22H23N3O3

If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>

Pricing & Availability

1,162

Medchemexpress LLC m-PEG4-sulfonic acid | 787524-78-1 | 97.0% | 272.32 | 50 MG

m-PEG4-sulfonic acid is a PEG-based PROTAC linker that can be utilized in the synthesis of PROTACs. PROTACs consist of two different ligands connected by a linker; one ligand is for an E3 ubiquitin ligase, and the other for the target protein. PROTACs operate by exploiting the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

PEG-based PROTAC linker
Utilized in the synthesis of PROTACs
Exploits the intracellular ubiquitin-proteasome system
Selectively degrades target proteins
For research use only

Pricing & Availability

1,163

eMolecules 827320-61-6 | 1-(4-Sulfobutyl)pyridin-1-ium hydrogen sulfate | Ambeed313.340 | C9H15NO7S2 | 97.000 | OS([O-])(=O)=O.OS(=O)(=O)CCCC[n+]1ccccc1 | 1g | 660582673

1-(4-Sulfobutyl)pyridin-1-ium hydrogen sulfate | Ambeed | 827320-61-6313.340 | C9H15NO7S2 | 97.000 | OS([O-])(=O)=O.OS(=O)(=O)CCCC[n+]1ccccc1 | 1g | 660582673

Pricing & Availability

1,164

eMolecules 76-61-9 | Ambeed | 33-Bis(4-hydroxy-5-isopropyl-2-methylphenyl)-3H-benzo[c][12]oxathiole 11-dioxide | 5g | 552755080 | A750751 | MFCD00005869 | 466.59 | C27H30O5S

Ambeed | 33-Bis(4-hydroxy-5-isopropyl-2-methylphenyl)-3H-benzo[c][12]oxathiole 11-dioxide | 5g | 552755080 | A750751 | 76-61-9 | MFCD00005869 | 466.590 | C27H30O5S

Pricing & Availability

1,165

Medchemexpress LLC ASN007 benzenesulfonate (ERK-IN-3 benzenesulfonate) | 2055597-39-0 | 99.7% | 632.11 | 100 MG

ASN007 (ERK-IN-3) benzenesulfonate is a potent and orally active inhibitor of ERK. It demonstrates potent inhibition of ERK1/2 with low single-digit nanomolar IC50 values. This compound exhibits significant antiproliferative activity against various tumor cells and is suitable for research into cancers driven by RAS mutations.

Potent and orally active ERK inhibitor
Inhibits ERK1/2 with low single-digit nM IC50 values
Exhibits significant antiproliferative activity against various tumor cells
Useful for research of cancers driven by RAS mutations
Inhibits the phosphorylation of ERK1/2 substrates (e.g., RSK1, FRA1, Elk1) in various cell lines
Induces G0/G1 phase cell cycle arrest in various cells
Significantly inhibits tumor growth and shows good tolerance in nude mice bearing BRAF and KRAS mutant xenograft tumors